Health In Tech Inc

News & Events zu Health In Tech Inc (HIT)

$0.524

-0.048 (-9.14%)Zum Schluss

HIT-News

HIT-Events

10/20 07:00

Health In Tech Appoints Sanjay Shrestha as CEO

Health In Tech announced the appointment of Sanjay Shrestha as CEO, effective October 20. Shrestha will succeed founder Tim Johnson, who will transition to executive chairman of the board of directors of the company on the same date. The company intends to evaluate potential acquisitions, strategic investments, partnerships and complementary business opportunities. Shrestha previously served as an independent director of Health In Tech from April 2025 to August.

9/30 16:30

Health In Tech Launches HitRix Platform, Shares Up 23%

Shares of Health In Tech are moving higher after the company announced the launch of HitRix, a new AI-powered platform "designed to simplify one of the most complex and manual workflows in the large-group self-funded health insurance market." Health In Tech expects HitRix, the company's three-year rate stabilization program and expanded carrier capacity to become more meaningful growth contributors beginning in 2027 and beyond. It said, "For brokers serving larger employers, bringing a case to market can require collecting significant volumes of employee census information, claims data, plan documents and other sensitive information; organizing files received in multiple formats; preparing submissions for different carriers and managing general underwriters; tracking responses; and manually comparing proposals. HitRix is designed to simplify that process." The company also guided its 2026 revenue to $33M, roughly in line with 2025 revenue, and below the consensus estimate of $41.19M. Shares of Health In Tech are up 23% in after-hours trading to $1.01.

9/30 16:30

Health In Tech Updates 2026 Revenue Outlook to $33 Million

Health In Tech said when announcing the launch of HitRix, its new AI-powered platform, "The Company also updated its full-year 2026 revenue outlook to approximately $33 million, roughly in line with 2025 revenue, primarily reflecting the timing of several strategic initiatives during 2026. Health In Tech expects HitRix, the Company's Three-Year Rate Stabilization Program, which is a differentiated solution designed to provide employers with greater predictability in stop-loss pricing over a multi-year period, and expanded carrier capacity, to become more meaningful growth contributors beginning in 2027 and beyond...This revised outlook primarily reflects the timing of HitRix commercialization, the Three-Year Rate Stabilization Program and additional carrier capacity, which affect the timing of new policy effective dates and related revenue recognition. The Company expects these initiatives to contribute more meaningfully in 2027 and beyond as adoption increases, carrier capacity expands and new business becomes effective."

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln